Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 55N34 | — |
patient received Bexsero inadvertently, the patient was supposed to receive Menveo; This non-serious case was reported by a nurse and described the occurrence of wrong vaccine administered in a 11-year-old male patient who received Men B NVS (Bexsero) (batch number 55N34, expiry date 30-SEP-2027) for prophylaxis. Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis. On 17-JUL-2025, the patient received Bexsero. The patient did not receive Menveo. On 17-JUL-2025, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: patient received Bexsero inadvertently, the patient was supposed to receive Menveo). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-JUL-2025 The reporter stated that a patient received Bexsero inadvertently, the patient was supposed to receive Menveo, which led to wrong vaccine administered.